Effect of Ketoconazole on the plasma pharmacokinetics of Axitinib (AG-013736) in healthy volunteers

被引：0

作者：

Pithavala, Yazdi

Klamerus, Karen

Garrett, May

Hee, Brian

Mount, Janessa

Selaru, Paulina

Sarapa, Nenad

机构：

[1] Pfizer Inc, San Diego, CA USA

[2] CPCS Pharma Consulting, Morristown, NJ USA

来源：

CANCER RESEARCH | 2008年 / 68卷 / 09期

关键词：

D O I：

暂无

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

232

引用

页数：2

共 50 条

[11] Development of an efficient Pd catalyzed process for Axitinib (AG-013736) [J].

Srirangam, Jay K. ;

Yu, Shu ;

Singer, Rob ;

Flahive, Erik ;

Sach, Neal ;

Tian, Qingping ;

Babu, Srin ;

Saenz, James .

ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2012, 243

[12] Axitinib (AG-013736) in patients with metastatic melanoma: A phase II study [J].

Fruehauf, J. P. ;

Lutzky, J. ;

McDermott, D. F. ;

Brown, C. K. ;

Pithavala, Y. K. ;

Bycott, P. W. ;

Shalinsky, D. ;

Liau, K. F. ;

Niethammer, A. ;

Rixe, O. .

JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)

[13] PHARMACOKINETICS ( PK) OF AXITINIB ( AG-013736; AG) IN SUBJECTS WITH HEPATIC IMPAIRMENT COMPARED WITH THOSE WITH NORMAL HEPATIC FUNCTION. [J].

Tortorici, M. A. ;

Toh, M. ;

Rahavendran, S. V. ;

LaBadie, R. R. ;

Marbury, T. ;

Fuentes, E. ;

Green, M. ;

Ni, G. ;

Hee, B. ;

Alvey, C. W. ;

Pithavala, Y. K. .

CLINICAL PHARMACOLOGY & THERAPEUTICS, 2010, 87 :S76-S76

[14] A phase 2 study of axitinib (AG-013736; AG) in patients (pts) with advanced thyroid cancers [J].

Cohen, E. ;

Vokes, E. E. ;

Rosen, L. S. ;

Kies, M. S. ;

Forastiere, A. A. ;

Worden, F. P. ;

Kane, M. A. ;

Liau, K. F. ;

Shalinsky, D. R. ;

Cohen, R. B. .

EJC SUPPLEMENTS, 2007, 5 (04) :326-326

[15] A phase II study of axitinib (AG-013736) in patients with incurable adenoid cystic carcinoma [J].

Ho, A. L. ;

Dunn, L. ;

Sherman, E. J. ;

Fury, M. G. ;

Baxi, S. S. ;

Chandramohan, R. ;

Dogan, S. ;

Morris, L. G. T. ;

Cullen, G. D. ;

Haque, S. ;

Sima, C. S. ;

Ni, A. ;

Antonescu, C. R. ;

Katabi, N. ;

Pfister, D. G. .

ANNALS OF ONCOLOGY, 2016, 27 (10) :1902-1908

[16] A phase II study of axitinib (AG-013736 [AG]) in patients (pts) with advanced thyroid cancers [J].

Cohen, E. E. ;

Vokes, E. E. ;

Rosen, L. S. ;

Kies, M. S. ;

Forastiere, A. A. ;

Worden, F. P. ;

Kane, M. A. ;

Liau, K. F. ;

Shalinsky, D. R. ;

Cohen, R. B. .

JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)

[17] Effect of axitinib (AG-013736) on thyroid function and biomarkers: Results from phase studies in Japanese patients [J].

Fujiwara, Yutaka ;

Kiyota, Naomi ;

Chayahara, Naoko ;

Suzuki, Akiyuki ;

Umeyama, Yoshiko ;

Mukohara, Toru ;

Minami, Hironobu .

MOLECULAR CANCER THERAPEUTICS, 2009, 8 (12)

[18] Commercial route development for axitinib/AG-013736, solid form and control strategy challenges [J].

Singer, Robert .

ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2012, 244

[19] Evaluation of the effect of food on the pharmacokinetics of axitinib in healthy volunteers [J].

Yazdi K. Pithavala ;

Ying Chen ;

Melvin Toh ;

Paulina Selaru ;

Robert R. LaBadie ;

May Garrett ;

Brian Hee ;

Janessa Mount ;

Grace Ni ;

Karen J. Klamerus ;

Michael A. Tortorici .

Cancer Chemotherapy and Pharmacology, 2012, 70 :103-112

[20] Evaluation of the effect of food on the pharmacokinetics of axitinib in healthy volunteers [J].

Pithavala, Yazdi K. ;

Chen, Ying ;

Toh, Melvin ;

Selaru, Paulina ;

LaBadie, Robert R. ;

Garrett, May ;

Hee, Brian ;

Mount, Janessa ;

Ni, Grace ;

Klamerus, Karen J. ;

Tortorici, Michael A. .

CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2012, 70 (01) :103-112

← 1 2 3 4 5 →